Literature DB >> 16410029

Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

Jun-ichi Jinno1, Naoki Kamada, Masateru Miyake, Keigo Yamada, Tadashi Mukai, Masaaki Odomi, Hajime Toguchi, Gary G Liversidge, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

The purpose of the present study was to investigate the effects of particle size on the dissolution and oral absorption of cilostazol. Three types of suspensions having different particle size distributions were prepared of the hammer-milled, the jet-milled cilostazol crystals and the NanoCrystal spray-dried powder of cilostazol. In vitro dissolution rate of cilostazol was significantly increased by reducing the particle size. The dissolution curves of the cilostazol suspensions were in good agreement with the simulation based on the Noyes-Whitney equation. The bioavailability of cilostazol after oral administration to dogs was increased with reducing the particle size. While positive food effect on the absorption was observed for the suspensions made of the hammer-milled and the jet-milled crystals, no significant food effect was found for the suspension made of the NanoCrystal cilostazol spray-dried powder. These results could be qualitatively predicted from the in vitro dissolution data using the bio-relevant media, FaSSIF and FeSSIF. In conclusion, the NanoCrystal technology is found to be efficient to improve the oral bioavailability of cilostazol and to avoid the food effect on the absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410029     DOI: 10.1016/j.jconrel.2005.11.013

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  52 in total

Review 1.  Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds.

Authors:  Filippos Kesisoglou; Amitava Mitra
Journal:  AAPS J       Date:  2012-06-27       Impact factor: 4.009

2.  A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

3.  Comparative oral bioavailability advantage from curcumin formulations.

Authors:  Bhushan Munjal; Yogesh Bapurao Pawar; Sarsvatkumar Babulal Patel; Arvind Kumar Bansal
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

4.  The role of particle size of glyburide crystals in improving its oral absorption.

Authors:  Wenqian Yang; Yongjun Wang; Qiang Fu; Zhibin Guo; Bingjun Sun; Wen Liu; Yaxuan Liu; Simeng Mu; Mengran Guo; Jingru Li; Xiaohui Pu; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

5.  Enhanced percutaneous absorption of cilostazol nanocrystals using aqueous gel patch systems and clarification of the absorption mechanism.

Authors:  Chiaki Yoshioka; Yoshimasa Ito; Noriaki Nagai
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

6.  Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect.

Authors:  Hefei Zhang; Binfeng Xia; Jennifer Sheng; Tycho Heimbach; Tsu-Han Lin; Handan He; Yanfeng Wang; Steven Novick; Ann Comfort
Journal:  AAPS PharmSciTech       Date:  2014-01-17       Impact factor: 3.246

7.  Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy.

Authors:  Hans de Waard; Thomas De Beer; Wouter L J Hinrichs; Chris Vervaet; Jean-Paul Remon; Henderik W Frijlink
Journal:  AAPS J       Date:  2010-07-13       Impact factor: 4.009

Review 8.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

9.  Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Authors:  Takeshi Io; Toshiro Fukami; Kazutoshi Yamamoto; Toyofumi Suzuki; Jiadi Xu; Kazuo Tomono; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

10.  An oral formulation of cilostazol nanoparticles enhances intestinal drug absorption in rats.

Authors:  Chiaki Yoshioka; Yoshimasa Ito; Noriaki Nagai
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.